Press
releases

Aug 29, 2024

Ultragenyx to Participate in Investor Conferences in September

Read more

Aug 21, 2024

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

Aug 01, 2024

Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update

Read more

Jul 25, 2024

Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update

Read more

Jul 24, 2024

Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium

Read more

Jul 19, 2024

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

Jul 17, 2024

Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program

Read more

Jun 20, 2024

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more

Jun 13, 2024

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Read more

Jun 12, 2024

Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Read more